Cancer-specific antigens are valuable targets for several treatment modalities:
- Immunotherapy: Therapies like checkpoint inhibitors and CAR-T cell therapy target cancer-specific antigens to boost the immune system's ability to fight cancer. - Vaccines: Cancer vaccines aim to stimulate the immune system to recognize and attack cancer cells expressing specific antigens. Examples include vaccines targeting the HPV virus to prevent cervical cancer. - Monoclonal Antibodies: Drugs like trastuzumab (targeting HER2) and rituximab (targeting CD20) are designed to bind specific antigens on cancer cells, leading to their destruction.
